AIGH Capital Management LLC - Q4 2022 holdings

$304 Million is the total value of AIGH Capital Management LLC's 97 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 50.0% .

 Value Shares↓ Weighting
DZSI BuyDZS INC$22,662,647
+19.5%
1,787,275
+6.5%
7.47%
+26.7%
BuyADTRAN HOLDINGS INC$22,170,678
-2.5%
1,179,919
+1.6%
7.30%
+3.4%
TGAN SellTRANSPHORM INC$19,634,842
+3.5%
3,609,346
-4.3%
6.47%
+9.7%
TELA BuyTELA BIO INC$19,311,732
+48.2%
1,679,281
+9.8%
6.36%
+57.1%
SCPH BuySCPHARMACEUTICALS INC$18,285,178
+270.4%
2,550,234
+236.9%
6.02%
+292.7%
INDI BuyINDIE SEMICONDUCTOR INC$17,829,556
+67.7%
3,058,243
+110.5%
5.87%
+77.7%
AVNW SellAVIAT NETWORKS INC$16,621,713
+13.3%
532,918
-0.6%
5.48%
+20.1%
ANIP BuyANI PHARMACEUTICALS INC$14,406,604
+42.6%
358,106
+13.9%
4.75%
+51.1%
BDSX NewBIODESIX INC$14,014,9936,093,475
+100.0%
4.62%
CMBM BuyCAMBIUM NETWORKS CORP$12,657,577
+3794.6%
584,106
+2945.1%
4.17%
+4028.7%
ASPN NewASPEN AEROGELS INC$11,790,0001,000,000
+100.0%
3.88%
CAMP SellCALAMP CORP$10,429,181
+16.2%
2,327,942
-0.4%
3.44%
+23.2%
AVEO SellAVEO PHARMACEUTICALS INC$10,395,602
-53.9%
695,358
-74.6%
3.42%
-51.1%
CTIC NewCTI BIOPHARMA CORP$8,449,2121,405,859
+100.0%
2.78%
PRTK BuyPARATEK PHARMACEUTICALS INC$7,773,386
-22.2%
4,156,891
+6.9%
2.56%
-17.5%
EOLS BuyEVOLUS INC$6,973,245
+333.1%
928,528
+364.3%
2.30%
+359.4%
BKTI BuyBK TECHNOLOGIES CORPORATION$5,609,884
+69.5%
1,689,724
+23.0%
1.85%
+79.6%
INFN NewINFINERA CORP$5,560,305824,971
+100.0%
1.83%
MRAM SellEVERSPIN TECHNOLOGIES INC$4,725,611
-4.5%
849,930
-0.5%
1.56%
+1.3%
AIRG SellAIRGAIN INC$4,722,901
-10.0%
725,484
-0.3%
1.56%
-4.5%
BuyCOGNITION THERAPEUTICS INC$4,279,491
+182.3%
2,037,853
+155.3%
1.41%
+199.4%
NewCOHERENT CORP$3,510,000100,000
+100.0%
1.16%
THTX BuyTHERATECHNOLOGIES INC$3,387,898
-51.0%
3,830,039
+31.5%
1.12%
-48.0%
APEN SellAPOLLO ENDOSURGERY INC$3,154,867
+12.6%
316,436
-37.8%
1.04%
+19.3%
SCYX SellSCYNEXIS INC$3,013,992
-35.8%
1,932,046
-1.3%
0.99%
-31.9%
NewCOYA THERAPEUTICS INC$2,653,336560,000
+100.0%
0.87%
RFIL SellRF INDS LTD$2,612,646
-11.3%
508,297
-0.7%
0.86%
-5.9%
LPTH SellLIGHTPATH TECHNOLOGIES INC$2,476,396
+13.4%
2,029,832
-0.5%
0.82%
+20.4%
SellIDEAL PWR INC$2,279,849
+3.3%
213,068
-0.1%
0.75%
+9.5%
NewPROSOMNUS INC$2,133,623390,640
+100.0%
0.70%
OSMT BuyRVL PHARMACEUTICALS PLC$2,018,087
+29.9%
1,801,864
+143.6%
0.66%
+37.7%
BuyABEONA THERAPEUTICS INC$2,008,696
+369.3%
652,174
+363.7%
0.66%
+397.7%
MDNA BuyMEDICENNA THERAPEUTICS CORP$1,991,985
-37.6%
4,346,983
+12.9%
0.66%
-33.9%
TFFP NewTFF PHARMACEUTICALS INC$1,826,0861,739,130
+100.0%
0.60%
FKWL  FRANKLIN WIRELESS CORP$1,739,400
+52.7%
390,0000.0%0.57%
+61.9%
VCNX BuyVACCINEX INC$1,664,394
+61.6%
2,451,801
+17.8%
0.55%
+71.2%
BuyCELLECTAR BIOSCIENCES INC$1,593,529
+171.9%
931,888
+434.3%
0.52%
+188.5%
SellCAPSTONE GREEN ENERGY CORP$1,299,925
-18.4%
896,500
-0.4%
0.43%
-13.5%
BCDA NewBIOCARDIA INC$1,244,046595,237
+100.0%
0.41%
NewKWESST MICRO SYSTEMS INC$1,032,000400,000
+100.0%
0.34%
SellSOLENO THERAPEUTICS INC$836,528
+18.2%
422,489
-0.4%
0.28%
+25.5%
SellCONTEXT THERAPEUTICS INC$745,379
-48.0%
1,143,745
-11.5%
0.25%
-44.8%
ADVM  ADVERUM BIOTECHNOLOGIES INC$695,400
-39.0%
1,200,0000.0%0.23%
-35.3%
NewKWESST MICRO SYSTEMS INCcall$539,100599,000
+100.0%
0.18%
PCSA  PROCESSA PHARMACEUTICALS INC$334,073
-51.3%
303,7030.0%0.11%
-48.4%
NLSPW BuyNLS PHARMACEUTICS LTDcall$239,807
+389.4%
826,921
+326.1%
0.08%
+426.7%
CYTHW BuyCYCLO THERAPEUTICS INCcall$140,542
+440.5%
270,274
+266.5%
0.05%
+475.0%
BuySAVERONE 2014 LTDcall$56,805
+35.2%
569,194
+302.6%
0.02%
+46.2%
RZLT  REZOLUTE INC$24,563
-25.6%
11,8660.0%0.01%
-20.0%
ExitPARABELLUM ACQUISITION CORPcall$0-139,072
-100.0%
-0.00%
ExitPARABELLUM ACQUISITION CORP*w exp 99/99/999$0-450,214
-100.0%
-0.00%
CYTHW ExitCYCLO THERAPEUTICS INC*w exp 11/14/202$0-219,795
-100.0%
-0.02%
ExitSAVERONE 2014 LTD*w exp 06/02/202$0-428,330
-100.0%
-0.04%
NLSPW ExitNLS PHARMACEUTICS LTD*w exp 09/25/202$0-633,361
-100.0%
-0.05%
ATNX ExitATHENEX INC$0-1,000,134
-100.0%
-0.08%
NBSE ExitNEUBASE THERAPEUTICS INC$0-872,023
-100.0%
-0.11%
MYO ExitMYOMO INC$0-617,179
-100.0%
-0.31%
RNAZ ExitTRANSCODE THERAPEUTICS INC$0-1,289,000
-100.0%
-0.44%
XFOR ExitX4 PHARMACEUTICALS INC$0-997,719
-100.0%
-0.53%
ARDX ExitARDELYX INC$0-1,487,476
-100.0%
-0.55%
ICAD ExitICAD INC$0-1,755,634
-100.0%
-1.15%
SIMO ExitSILICON MOTION TECHNOLOGY COsponsored adr$0-114,400
-100.0%
-2.32%
ExitSONO GROUP N V$0-3,516,129
-100.0%
-2.78%
MTRN ExitMATERION CORP$0-241,189
-100.0%
-6.00%
IWM ExitISHARES TRput$0-410,000
-100.0%
-21.01%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AVIAT NETWORKS INC12Q3 20236.8%
SCPHARMACEUTICALS INC12Q3 20238.5%
THERATECHNOLOGIES INC11Q2 20232.9%
FRANKLIN WIRELESS CORP11Q3 20232.9%
IDEAL PWR INC11Q3 20232.5%
MEDICENNA THERAPEUTICS CORP11Q3 20231.1%
PARATEK PHARMACEUTICALS INC10Q1 20233.2%
LIGHTPATH TECHNOLOGIES INC10Q3 20233.0%
MYOMO INC10Q3 20231.3%
DZS INC9Q1 20237.5%

View AIGH Capital Management LLC's complete holdings history.

Latest significant ownerships (13-D/G)
AIGH Capital Management LLC Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Bridgeline Digital, Inc.May 21, 2021627,4199.7%

View AIGH Capital Management LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-02-12
13F-HR2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-15
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-12
13F-HR2022-02-10

View AIGH Capital Management LLC's complete filings history.

Compare quarters

Export AIGH Capital Management LLC's holdings